ONCT vs. ARWR
ONCT (Oncternal Therapeutics, Inc.) and ARWR (Arrowhead Pharmaceuticals, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. At a correlation of -0.09, they often move in opposite directions.
Performance
ONCT vs. ARWR - Performance Comparison
Loading charts...
Returns By Period
ONCT
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ARWR
- 1D
- 2.44%
- 1M
- -5.03%
- YTD
- 9.28%
- 6M
- 11.49%
- 1Y
- 336.79%
- 3Y*
- 26.25%
- 5Y*
- -0.96%
- 10Y*
- 28.05%
ONCT vs. ARWR - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
ONCT Oncternal Therapeutics, Inc. | 0.00% |
ARWR Arrowhead Pharmaceuticals, Inc. | 12.45% |
Correlation
The correlation between ONCT and ARWR is -0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Feb 9, 2026 | -0.09 |
Fundamentals
ONCT:
$1.67M
ARWR:
$622.01M
ONCT:
-$16.96M
ARWR:
$529.27M
ONCT:
-$17.87M
ARWR:
-$168.38M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ONCT vs. ARWR — Risk / Return Rank
ONCT
ARWR
ONCT vs. ARWR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Oncternal Therapeutics, Inc. (ONCT) and Arrowhead Pharmaceuticals, Inc. (ARWR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| ONCT | ARWR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 5.22 | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.01 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.38 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 1.68 | -0.01 | +1.69 |
Drawdowns
ONCT vs. ARWR - Drawdown Comparison
The maximum ONCT drawdown since its inception was 0.00%, smaller than the maximum ARWR drawdown of -99.24%. Use the drawdown chart below to compare losses from any high point for ONCT and ARWR.
Loading charts...
Drawdown Indicators
| ONCT | ARWR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | 0.00% | -99.24% | +99.24% |
Max Drawdown (1Y)Largest decline over 1 year | — | -24.64% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -74.70% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -88.94% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -88.96% | — |
Current DrawdownCurrent decline from peak | 0.00% | -55.35% | +55.35% |
Average DrawdownAverage peak-to-trough decline | 0.00% | -81.24% | +81.24% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 8.97% | — |
Volatility
ONCT vs. ARWR - Volatility Comparison
Loading charts...
Volatility by Period
| ONCT | ARWR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 17.17% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 39.41% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 0.00% | 65.03% | -65.03% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 0.00% | 65.03% | -65.03% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 0.00% | 74.14% | -74.14% |
Dividends
ONCT vs. ARWR - Dividend Comparison
Neither ONCT nor ARWR has paid dividends to shareholders.
Financials
ONCT vs. ARWR - Financials Comparison
This section allows you to compare key financial metrics between Oncternal Therapeutics, Inc. and Arrowhead Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ONCT and ARWR have a correlation of -0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for ONCT and ARWR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer